- Investing Ideas
- /
- German Pharmaceuticals & Biotech Top Stock Picks from Analysts
German Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
9
Companies which are more than 50% undervalued based on analyst price target.
9 companies
Dermapharm Holding
Market Cap: €1.7b
Manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.
DMP
€32.40
7D
-2.8%
1Y
-7.8%
Evotec
Market Cap: €1.2b
Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
EVT
€6.58
7D
-1.8%
1Y
10.8%
Formycon
Market Cap: €441.4m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€25.35
7D
-0.2%
1Y
-50.2%
Heidelberg Pharma
Market Cap: €197.1m
A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, the United States, and internationally.
HPHA
€4.23
7D
-1.2%
1Y
70.6%
MPH Health Care
Market Cap: €75.4m
An investment company, engages in the healthcare business in Germany.
93M1
€17.55
7D
-1.1%
1Y
-12.3%
Cantourage Group
Market Cap: €51.9m
Operates as a medical cannabis company in Europe.
HIGH
€4.16
7D
2.7%
1Y
-23.0%
Vidac Pharma Holding
Market Cap: €26.8m
An investment holding company, engages in the discovery and development of medicines for oncologic and dermatologic diseases.
T9G
€0.47
7D
-8.7%
1Y
112.1%
SynBiotic
Market Cap: €24.5m
Engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety.
SBX
€3.59
7D
0%
1Y
-44.9%
Medigene
Market Cap: €1.1m
A biotechnology company, focuses on the discovery and development of T-cell therapies for the treatment of cancer.
MDG1
€0.068
7D
-38.8%
1Y
-97.1%